Serum Institute CEO Adar Poonawalla has said that the vaccine shortage could continue for months amid India's devastating second wave of coronavirus. He said that the shortage could continue through July, which is when production is expected to increase to 100 million a month from the current 60-70 million. "Everybody really felt that India had started to turn the tide on the pandemic," said Poonawalla to Financial Times, adding that the authorities did not expect to confront a second wave back in January, when cases had started declining.

Serum Institute CEO Adar Poonawalla has said that the vaccine shortage could continue for months amid India's devastating second wave of coronavirus. He said that the shortage could continue through July, which is when production is expected to increase to 100 million a month from the current 60-70 million. "Everybody really felt that India had started to turn the tide on the pandemic," said Poonawalla to Financial Times, adding that the authorities did not expect to confront a second wave back in January, when cases had started declining.